Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Ocular Immunology and Inflammation, 2023
Non-Infectious Uveitis Secondary to Dupilumab Treatment in Atopic Dermatitis Patients Shows a Pro-Inflammatory Molecular Profile

Achten R., van Luijk C., Thijs J. et al.

Olink Target 96OphthalmologyDermatological DiseasesPathophysiologyAqueous Humor

eBioMedicine, 2023
Association between proteomic biomarkers and myocardial fibrosis measured by MRI: the multi-ethnic study of atherosclerosis

Bakhshi H., Michelhaugh S., Bruce S. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Biomedicines, 2023
Inflammatory Blood Signature Related to Common Psychological Comorbidity in Chronic Pain

Karshikoff B., Wåhlén K., Åström J. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Arthritis Research & Therapy, 2023
TGF-β is elevated in hyperuricemic individuals and mediates urate-induced hyperinflammatory phenotype in human mononuclear cells

Klück V., Cabău G., Mies L. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

PROTEOMICS – Clinical Applications, 2023
Analytical validation of a multi‐protein, serum‐based assay for disease activity assessments in multiple sclerosis

Qureshi F., Hu W., Loh L. et al.

Olink FocusNeurologyPatient StratificationTechnical EvaluationSerum

Cytopathology, 2023
Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade

Röbeck P., Franzén B., Cantera‐Ahlman R. et al.

Olink Target 96OncologyPatient StratificationFine Needle Aspirate

Molecular Medicine, 2023
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning

Patel M., Knauer M., Nicholson M. et al.

Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma

Alzheimer's & Dementia, 2023
Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology

Wolzak K., Vermunt L., Campo M. et al.

Olink Target 96NeurologyPathophysiologyCSF

Respiratory Research, 2023
Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia

Palma Medina L., Babačić H., Dzidic M. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Journal of the Endocrine Society, 2023
Association Between Metabolic Syndrome Inflammatory Biomarkers and COVID-19 Severity

Pham T., Zu Y., Ghamsari F. et al.

Olink Explore 3072/384Metabolic DiseasesInfectious DiseasesPatient StratificationPlasma

Nature Metabolism, 2023
Proteogenomic mapping sets stage for precision medicine

Coral D., Franks P.

Olink Explore 3072/384Wider Proteomics StudiesReview/editorial

Nature Metabolism, 2023
Proteogenomic links to human metabolic diseases

Koprulu M., Carrasco-Zanini J., Wheeler E. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologySerum

Nature Communications, 2023
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial

Othonos N., Pofi R., Arvaniti A. et al.

Olink Target 48Immunological & Inflammatory DiseasesPathophysiologySerum

JCI Insight, 2023
Vitamin D3 and deconvoluting a rash

Ernst M., Evans S., Techner J. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationPlasma

Journal of Allergy and Clinical Immunology, 2023
Proteomic and transcriptomic screening demonstrates increased mast cell–derived CCL23 in systemic mastocytosis

Söderlund S., Boey D., van Midden W. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Life Science Alliance, 2023
Plasma proteome dynamics of COVID-19 severity learnt by a graph convolutional network of multi-scale topology

Gauthier S., Tran-Dinh A., Morilla I.

Olink Explore 3072/384Infectious DiseasesData SciencePlasma

Gut Microbes, 2023
Randomized controlled trial demonstrates response to a probiotic intervention for metabolic syndrome that may correspond to diet

Wastyk H., Perelman D., Topf M. et al.

Olink Target 96Metabolic DiseasesNutritional SciencePathophysiologyPlasma

Inflammation Research, 2023
Screening inflammatory protein biomarkers on premature infants with necrotizing enterocolitis

Dong H., Zhang L., Li B. et al.

Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma

The Journal of Clinical Endocrinology & Metabolism, 2023
Disease Duration and Chronic Complications Associate With Immune Activation in Individuals With Longstanding Type 1 Diabetes

Ajie M., van Heck J., Janssen A. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

BJU International, 2023
Urine supernatant reveals a signature that predicts survival in clear‐cell renal cell carcinoma

Daza J., Salomé B., Okhawere K. et al.

Olink Target 96OncologyPatient StratificationPlasmaUrine

4265 publications